Magnum Experiment 16

The chart shows the growth of an initial investment of $10,000 in Magnum Experiment 16, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced Every 3 months.

As of Apr 2, 2026, the Magnum Experiment 16 returned 0.03% Year-To-Date and 21.25% of annualized return in the last 10 years.

Based on dividend-adjusted daily data since Aug 7, 2009, Magnum Experiment 16's average daily return is +0.08%, while the average monthly return is +1.61%. At this rate, your investment would double in approximately 3.6 years.

Historically, 71% of months were positive and 29% were negative. The best month was Mar 2022 with a return of +10.3%, while the worst month was Mar 2020 at -11.0%. The longest winning streak lasted 12 consecutive months, and the longest losing streak was 4 months.

On a daily basis, Magnum Experiment 16 closed higher 56% of trading days. The best single day was Mar 13, 2020 with a return of +7.4%, while the worst single day was Mar 12, 2020 at -9.4%.

Magnum Experiment 16 has an annualized alpha of 10.26%, beta of 0.77, and R² of 0.81 versus S&P 500 Index. Calculated based on daily prices since August 07, 2009.

• This portfolio captured 100.84% of S&P 500 Index gains but only 56.74% of its losses — a favorable profile for investors.
• This portfolio generated an annualized alpha of 10.26% versus S&P 500 Index — delivering returns beyond what market exposure alone would predict.

Magnum Experiment 16 has an expense ratio of 0.06%, which is considered low. Below, you can find the expense ratios of the portfolio's funds side by side and easily compare their relative costs.

Magnum Experiment 16 ranks 2 for risk / return — in the bottom 2% of portfolios on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.

Magnum Experiment 16 Sharpe ratios as of Apr 2, 2026 (values are recalculated daily):

• 1-Year: -0.31
• 5-Year: 1.40
• 10-Year: 1.41
• All Time: 1.38

These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns (including price changes and dividends).

Compared to the broad market, where average Sharpe ratios range from 1.00 to 1.70, this portfolio's current Sharpe ratio places it in the bottom 25%. This suggests weaker risk-adjusted returns than most portfolios, possibly due to lower returns, higher volatility, or both. It may be worth reviewing the allocation. You can use the Portfolio Optimization tool to explore options for improving the Sharpe ratio.

The chart below shows the rolling Sharpe ratio of Magnum Experiment 16 compared to the selected benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.

Magnum Experiment 16 provided a 1.65% dividend yield over the last twelve months.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Magnum Experiment 16. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Magnum Experiment 16 was 28.54%, occurring on Mar 23, 2020. Recovery took 85 trading sessions.

The current Magnum Experiment 16 drawdown is 8.22%.

The chart below shows the rolling one-month volatility.